420 related articles for article (PubMed ID: 18520954)
1. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors.
Galderisi M; de Divitiis O
J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954
[TBL] [Abstract][Full Text] [Related]
2. [Resistance to ACE inhibitors. Myth or reality?].
Aumont MC; Juliard JM
Arch Mal Coeur Vaiss; 2001 Sep; 94(9):1008-12. PubMed ID: 11603063
[TBL] [Abstract][Full Text] [Related]
3. [ACE-inhibitors and cardiovascular protection].
Agabiti-Rosei E; Muiesan ML
Cardiologia; 1994 Dec; 39(12 Suppl 1):139-47. PubMed ID: 7634257
[TBL] [Abstract][Full Text] [Related]
4. What is the role of angiotensin-receptor blockade in cardiovascular protection?
Cohn JN
Am Heart J; 2006 Nov; 152(5):859.e1-8. PubMed ID: 17070145
[TBL] [Abstract][Full Text] [Related]
5. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
Neutel JM
J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
[TBL] [Abstract][Full Text] [Related]
6. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
Izzo JL
Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
[TBL] [Abstract][Full Text] [Related]
7. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
Healey JS; Morillo CA; Connolly SJ
Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
[TBL] [Abstract][Full Text] [Related]
8. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide.
Gibbons GH
Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-18-25. PubMed ID: 9422848
[TBL] [Abstract][Full Text] [Related]
9. [Left ventricular remodeling in arterial hypertension and its therapy].
Dúbrava J
Vnitr Lek; 1998 Jan; 44(1):50-6. PubMed ID: 9750485
[TBL] [Abstract][Full Text] [Related]
10. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme and vascular remodeling.
Heeneman S; Sluimer JC; Daemen MJ
Circ Res; 2007 Aug; 101(5):441-54. PubMed ID: 17761934
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
13. [Left ventricular hypertrophy in chronic kidney disease].
Paoletti E; Cannella G
G Ital Nefrol; 2006; 23(6):560-8. PubMed ID: 17173262
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
15. [Aldosterone and cardiovascular diseases, more than water and salt retention].
Duprez D
Verh K Acad Geneeskd Belg; 2002; 64(3):225-32. PubMed ID: 12238244
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition and vascular structure in hypertension.
Gibbons GH
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S19-24. PubMed ID: 1725196
[TBL] [Abstract][Full Text] [Related]
17. Vascular protection: current possibilities and future perspectives.
Lüscher TF
Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
[TBL] [Abstract][Full Text] [Related]
18. Interactions of angiotensin-converting enzyme, kinins and nitric oxide in circulation and the beneficial effects of ACE inhibitors in cardiovascular diseases.
Magen E; Viskoper RJ
Isr Med Assoc J; 2000 Dec; 2(12):929-34. PubMed ID: 11344778
[TBL] [Abstract][Full Text] [Related]
19. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
Sesin J; Tamargo J
Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin-converting enzyme inhibitors on cerebral vascular structure in chronic hypertension.
Baumbach GL; Chillon JM
J Hypertens Suppl; 2000 May; 18(1):S7-11. PubMed ID: 10939784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
